Court Sanctions ImClone, IP Attorneys

Law360, New York (June 11, 2007, 12:00 AM EDT) -- A court imposed sanctions on Friday against pharmaceutical company ImClone Inc. and its attorneys for allegedly intimidating a witness in a patent infringement suit. MIT first moved for sanctions in March of 2006 in response to questions directed at one of its expert witnesses.

“The questioning was...undertaken as part of a deliberate stratagem to deprive MIT of [the witness's] services,” the judge's decision said.

The suit was brought by the Massachusetts Institute of Technology and pharmaceutical company Repligen Corp. over ImClone's profitable cancer drug Erbitux. MIT...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.